Structure-based design of potent CDK4 selective inhibitor.

被引：0

作者：

Honma, T ^{[1
]}

Hayashi, K ^{[1
]}

Kawanishi, N ^{[1
]}

Yoshizumi, T ^{[1
]}

Hashimoto, N ^{[1
]}

Sugimoto, T ^{[1
]}

Nakamura, K ^{[1
]}

Takaki, T ^{[1
]}

Machida, T ^{[1
]}

Fukasawa, K ^{[1
]}

Hirai, H ^{[1
]}

Iwama, T ^{[1
]}

Ikeura, C ^{[1
]}

Ikuta, M ^{[1
]}

Kamata, K ^{[1
]}

Suzuki-Takahashi, I ^{[1
]}

Hayama, T ^{[1
]}

机构：

[1] Banyu Pharmaceut Co Ltd, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 221卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

136-MEDI

引用

页码：U24 / U24

页数：1

共 50 条

[41] A phase I and pharmacokinetic (PK) study of continuous daily administration of P1446A-05, a potent and specific oral Cdk4 inhibitor.
Hao, Desiree
Chu, Quincy
Welch, Stephen
Yau, Cindy Y. F.
Spratlin, Jennifer L.
Tang, Patricia
MacKenzie, Mary J.
Townsley, Carol A.
Arndt, Diane
Johnson, Laureen
Trapsa, Daniela
Degendorfer, Pamela
Kulkarni, Sujay
Jawlekar, Gajendra
Dhobe, Poornima
Oza, Amit M.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[42] The effect of CDK4 inhibitor to AML
Wang, Jie
Briesewitz, Roger
ACTA PHARMACOLOGICA SINICA, 2006, 27 : 115 - 115
[43] The effect of CDK4 inhibitor to AML
wang, Jie
ACTA PHARMACOLOGICA SINICA, 2006, 27 : 62 - 62
[44] Preclinical evaluation of TQB3616, a highly potent and selective small-molecule CDK4/6 inhibitor
Xu Zhaobing
Hu Lihong
Liu Yingchun
Ding, Charles Z.
Zhu, Xiaoyu
Chen, Chen
Zhu, Yusong
Wu, Jiahu
Wu, Dongdong
Chen, Shuhui
Zhang, Xiquan
Yang, Ling
Tian, Xin
CANCER RESEARCH, 2018, 78 (13)
[45] Structure-based design of selective and potent inhibitors of protein-tyrosine phosphatase β
Lund, IK
Andersen, HS
Iversen, LF
Olsen, OH
Moller, KB
Pedersen, AK
Ge, Y
Holsworth, DD
Newman, MJ
Axe, FU
Moller, NPH
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (23) : 24226 - 24235
[46] Structure-based design of potent and selective tankyrase inhibitors to target the Wnt pathway
Chakka, Nagasree
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[47] Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors
Choi, Jun Yong
Fuerst, Rita
Knapinska, Anna M.
Taylor, Alexander B.
Smith, Lyndsay
Cao, Xiaohang
Hart, P. John
Fields, Gregg B.
Roush, William R.
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) : 5816 - 5825
[48] Structure-based design and discovery of potent and selective KDM5 inhibitors
Nie, Zhe
Shi, Lihong
Lai, Chon
O'Connell, Shawn M.
Xu, Jiangchun
Stansfield, Ryan K.
Hosfield, David J.
Veal, James M.
Stafford, Jeffrey A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (09) : 1490 - 1494
[49] Structure-based design of Trifarotene, a potent and selective RAR agonist for the treatment of acne
Thoreau, E.
Arlabosse, J.
Bouix-peter, C.
Chambon, S.
Chantalat, L.
Daver, S.
Dumais, L.
Duvert, G.
Feret, A.
Ouvry, G.
Pascau, J.
Raffin, C.
Rodeville, N.
Soulet, C.
Tabet, S.
Talano, S.
Portal, T.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (09) : B17 - B17
[50] Structure-based design of potent and selective tankyrase inhibitors to target the Wnt pathway
Hua, Zihao
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248

← 1 2 3 4 5 →